Archive

Latest Kaiser Health News Stories

Abortion Issue Helps Limit Democrats’ Losses in Midterms

KHN Original

Although control of Congress was still undecided Wednesday, Republicans seemed poised to take power in the House, while the fate of the Senate remained too close to call. Economic issues were at the top of voters’ minds, but abortion access also played a large role in their decisions.

Hospital Giant HCA Fends Off Accusations of Questionable Inpatient Admissions

KHN Original

The nation’s largest private health system, HCA Healthcare, has faced years of scrutiny over its share of emergency room patients who are admitted to the hospital. And now U.S. Rep. Bill Pascrell, a Democrat from New Jersey, is calling for a federal investigation, prompting an escalating defense by the hospital system, based in Nashville, Tennessee.

Centene Showers Politicians With Millions as It Courts Contracts and Settles Overbilling Allegations

KHN Original

Centene, the largest Medicaid managed-care company in the U.S., has thrown more than $26.9 million at political campaigns across the country since 2015, especially focused on states where it is wooing Medicaid contracts and settling accusations that it overbilled taxpayers. Among its tactics: Centene is skirting contribution limits by giving to candidates through its many subsidiaries.

KHN’s ‘What the Health?’: ACA Open Enrollment Without the Drama

KHN Original

The Affordable Care Act’s 10th annual open-enrollment period began Nov. 1 and runs through Jan. 15, 2023, in most states. But for the first time, the health law seems to be enrolling Americans with far less controversy than in previous years. Meanwhile, as Election Day approaches, Democrats are focusing on GOP efforts to cut Social Security and Medicare. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Tami Luhby of CNN, and Julie Appleby of KHN join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews KHN’s Arthur Allen, who wrote the latest KNH-NPR Bill of the Month, about an old but still very expensive cancer drug.